NCT00383487View on ClinicalTrials.gov

A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Prostatic NeoplasmsProstate Cancer
Interventions
DRUG

Calcitriol

0.5 micrograms/kilogram q weekly

DRUG

Naproxen-n-butyl nitrate

400 mg BID, oral

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Novacea
All Listed Sponsors
collaborator

Novacea

INDUSTRY

lead

Stanford University

OTHER